Pharming Group Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio55.2735.7526.30
P/S Ratio2.193.113.682.884.68
P/B Ratio2.943.493.692.965.41
Price/Tangible Book4.065.175.825.2310.47
Price/FCF35.8521.1012.57
Price/OCF33.6615.1111.87
Enterprise Value Ratios
EV/Revenue2.052.973.412.784.54
EV/EBITDA188.6940.9718.2211.66
EV/EBIT67.7023.0712.62
EV/FCF33.2920.4312.19
Profitability & Returns
Return on Equity (ROE)-0.05%-0.05%0.07%0.09%0.25%
Return on Assets (ROA)-0.01%-0.03%0.02%0.04%0.14%
Return on Invested Capital (ROIC)-0.02%-0.13%0.06%0.11%0.54%
Return on Capital Employed (ROCE)-0.01%-0.06%0.03%0.07%0.22%
Leverage & Solvency Ratios
Debt/Equity0.510.780.810.840.88
Debt/EBITDA17.028.464.881.92
Debt/FCF7.915.972.05
Liquidity Ratios
Current Ratio3.774.064.655.333.42
Quick Ratio2.963.283.904.693.08
Efficiency Ratios
Asset Turnover0.690.550.500.490.63
Inventory Turnover0.630.510.500.871.26
Yield & Distribution Ratios
Earnings Yield-0.02%-0.01%0.02%0.03%0.04%
FCF Yield0.00%-0.02%0.03%0.05%0.08%
Buyback Yield-0.02%0.07%-0.01%-0.03%-0.01%